CLINICAL_TRIALS
trial_result
· 2024-12-17
Clinical Trial Update: Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome [Phase 4]
Summary
Phase 4 study evaluating pharmacogenomics and pharmacometabolomics of acamprosate treatment in Alcohol Use Disorder; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Alcohol Use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2024-12-17